A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer

NCT00557037 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Phenoxodiol

Sponsor

MEI Pharma, Inc.